⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 12, 2024Oral Oncology ReportsOpen Access

Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing

Saravanan Sekaran Dhanraj Ganapathy

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

• HNSCC research faces challenges despite advancements in personalized medicine. • Patient derived tumor organoids lacks vascularization. • CAM model emerges as an efficient, ethical in vivo platform for HNSCC research. • CAM model enables personalized treatment evaluations and drug testing for HNSCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sekaran et al. (2024) studied this question.

synapsesocial.com/papers/68e6f717b6db643587671934 https://doi.org/10.1016/j.oor.2024.100360

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?2024
2Multimodal imaging of head and neck tumors in the chorioallantoic membrane assay as a basis for the establishment of new oncological therapies2024
3Head and neck cancer patient-derived tumouroid cultures: opportunities and challengesOriginal Research · 2023 · 19 citations
4An innervated and vascularized HNSCC-on-a-chip model built on defined and tunable engineered extracellular matricesOriginal Research · 2026
5Evaluating targeted drug therapies for pediatric tumors using the chick chorioallantoic membrane (CAM) xenograft modelHuman Clinical Trial · 2026
6Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma2024 · 5 citations
7Data from Genomic and Single-Cell Analyses Characterize Patient-Derived Tumor Organoids to Enable Personalized Therapy for Head and Neck Squamous Cell Carcinoma2025
8Establishment of head and neck cancer patient-derived xenografts PDX in the chorion-allantois membrane assay (CAM Assay)2024
9IRF1 reduces new genes expression and diminishes cell proliferation and invasiveness in OSCCOral Oncology Reports · 2026
10Patterns of facial (Level IX) node metastasis in head and neck cancer: Multicenter data supporting sublevel IXa/IXb delineationOral Oncology Reports · 2026

OMore from Oral Oncology Reports

More from Saveetha University